Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
rosuvastatin calcium, Quantity: 5.198 mg
Viteia Pty Ltd
Rosuvastatin calcium
Tablet, film coated
Excipient Ingredients: iron oxide red; crospovidone; light magnesium oxide; microcrystalline cellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; triacetin; allura red AC aluminium lake; quinoline yellow aluminium lake; indigo carmine aluminium lake
Oral
30, 7
(S4) Prescription Only Medicine
ALPHASTAT should be used as an adjunct to diet when the response to diet and exercise is inadequate.,Prevention of Cardiovascular Events:- ALPHASTAT is indicated for prevention of major cardiovascular events in men greater than or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking, or a family history of premature coronary heart disease)., ALPHASTAT is indicated to: ? Reduce the risk of nonfatal myocardial infarction ? Reduce the risk of nonfatal stroke ? Reduce the risk of coronary artery revascularisation procedures.,In patients with hypercholesterolaemia:- ALPHASTAT is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia).,Prior to initiating therapy with ALPHASTAT, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Visual Identification: A yellow, film coated, round, biconvex tablet, debossed with 'M' on one side and 'RS' on other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2013-03-08